Both in Biotechnology
Artiva Biotherapeutics vs Inhibikase Therapeutics
Over the past year ARTV returned +11.0% and IKT returned 0.0%; their daily moves had a correlation of 0.23.
ARTV +11.0% IKT 0.0%Growth of $1, one year, split-adjusted
| Metric | ARTV | IKT |
|---|---|---|
| Price | $4.20 | $1.48 |
| Market cap | $205.3M | $206.5M |
| Today | +0.24% | −3.90% |
| 1 month | −41.1% | −26.0% |
| 6 months | −60.4% | −23.3% |
| Year to date | −2.1% | −27.8% |
| 1 year | +0.7% | +0.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $349.4M | $159.0M |
| Dividend yield | — | — |
| Volatility (60d) | 93.3% | 50.9% |
| Short % of float | 20.1% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).